More from Investing
Obstacles that lie ahead, but this market never seems to embrace a negative narrative for long.
As psychedelic medicines begin to become decriminalized, psilocybin seems to be leading the way in this category.
For investors willing to take the risk, this could be an undervalued income stock.
I'm not looking to hold a trade until TSLA earnings in late October, I'm only looking out a week.